Occudo Quantitative Strategies’s Adverum Biotechnologies ADVM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,943
| Closed | -$30.9K | – | 935 |
|
|
2023
Q2 | $30.9K | Sell |
1,943
-3,313
| -63% | -$52.7K | ﹤0.01% | 969 |
|
|
2023
Q1 | $37.7K | Sell |
5,256
-2,578
| -33% | -$18.5K | ﹤0.01% | 855 |
|
|
2022
Q4 | $45.4K | Sell |
7,834
-174
| -2% | -$1.01K | 0.01% | 886 |
|
|
2022
Q3 | $76K | Hold |
8,008
| – | – | 0.01% | 1058 |
|
|
2022
Q2 | $96K | Hold |
8,008
| – | – | 0.01% | 1023 |
|
|
2022
Q1 | $105K | Sell |
8,008
-4,472
| -36% | -$58.6K | 0.01% | 1017 |
|
|
2021
Q4 | $220K | Buy |
12,480
+2,114
| +20% | +$37.3K | 0.02% | 864 |
|
|
2021
Q3 | $225K | Buy |
10,366
+1,856
| +22% | +$40.3K | 0.03% | 824 |
|
|
2021
Q2 | $298K | Buy |
8,510
+6,620
| +350% | +$232K | 0.05% | 595 |
|
|
2021
Q1 | $186K | Sell |
1,890
-4,344
| -70% | -$428K | 0.04% | 637 |
|
|
2020
Q4 | $676K | Buy |
+6,234
| New | +$676K | 0.21% | 140 |
|